key: cord-0921497-dcraq4ur
authors: Wei, Nancy; Kresch, Mindy; Elbogen, Emily; Lebwohl, Mark
title: New Onset and Exacerbation of Psoriasis After COVID-19 Vaccination
date: 2021-11-29
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.11.016
sha: 4d1544529fc491fbebd3f0014e57edf0542ba784
doc_id: 921497
cord_uid: dcraq4ur

nan

A retrospective review of the CDC VAERS of all reports from December 2020-August 2021 was 57 conducted using the search terms "psoriasis", "guttate psoriasis", "erythrodermic psoriasis".

Reports that were related to a non-COVID 19 vaccine such as for herpes zoster or influenza were 59 excluded from analysis. Reports that did not provide enough clinical information such as time to 1 Includes "biopsy", "biopsy skin" and "biopsy skin abnormal" 198

New onset guttate psoriasis following 152 pandemic H1N1 influenza vaccination

Widespread psoriasis flare following influenza vaccination. Vaccine

Psoriasis triggered by tetanusdiphtheria vaccination

Generalized exacerbation of 162 psoriasis vulgaris induced by pneumococcal polysaccharide vaccine

Double trouble: influenza and pneumococcal 166 vaccine exacerbation of psoriasis in a new-onset polycythemia vera patient

Cutaneous reactions reported after Moderna 177 and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

TH17 responses in cytokine storm of COVID-19: An emerging target of 180 JAK2 inhibitor Fedratinib

Center for Disease Control (CDC)

Vaccine Adverse Events Reporting System (VAERS)